Therapies for non-alcoholic fatty liver disease: A 2022 update

The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing and lifestyle interventions to treat this disease by addressing the underlying metabolic syndrome are often limited. Many pharmacological interventions are being studied to slow or even reverse NAFLD progression. This r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Katie, Singh, Achintya D, Modaresi Esfeh, Jamak, Wakim-Fleming, Jamile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521452/
https://www.ncbi.nlm.nih.gov/pubmed/36185717
http://dx.doi.org/10.4254/wjh.v14.i9.1718
_version_ 1784799841033912320
author Shen, Katie
Singh, Achintya D
Modaresi Esfeh, Jamak
Wakim-Fleming, Jamile
author_facet Shen, Katie
Singh, Achintya D
Modaresi Esfeh, Jamak
Wakim-Fleming, Jamile
author_sort Shen, Katie
collection PubMed
description The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing and lifestyle interventions to treat this disease by addressing the underlying metabolic syndrome are often limited. Many pharmacological interventions are being studied to slow or even reverse NAFLD progression. This review for hepatologists aims to provide an updated understanding of the pathogenesis of NAFLD, current recommended therapies, and the most promising treatment options that are currently under development.
format Online
Article
Text
id pubmed-9521452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-95214522022-09-30 Therapies for non-alcoholic fatty liver disease: A 2022 update Shen, Katie Singh, Achintya D Modaresi Esfeh, Jamak Wakim-Fleming, Jamile World J Hepatol Minireviews The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing and lifestyle interventions to treat this disease by addressing the underlying metabolic syndrome are often limited. Many pharmacological interventions are being studied to slow or even reverse NAFLD progression. This review for hepatologists aims to provide an updated understanding of the pathogenesis of NAFLD, current recommended therapies, and the most promising treatment options that are currently under development. Baishideng Publishing Group Inc 2022-09-27 2022-09-27 /pmc/articles/PMC9521452/ /pubmed/36185717 http://dx.doi.org/10.4254/wjh.v14.i9.1718 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Shen, Katie
Singh, Achintya D
Modaresi Esfeh, Jamak
Wakim-Fleming, Jamile
Therapies for non-alcoholic fatty liver disease: A 2022 update
title Therapies for non-alcoholic fatty liver disease: A 2022 update
title_full Therapies for non-alcoholic fatty liver disease: A 2022 update
title_fullStr Therapies for non-alcoholic fatty liver disease: A 2022 update
title_full_unstemmed Therapies for non-alcoholic fatty liver disease: A 2022 update
title_short Therapies for non-alcoholic fatty liver disease: A 2022 update
title_sort therapies for non-alcoholic fatty liver disease: a 2022 update
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521452/
https://www.ncbi.nlm.nih.gov/pubmed/36185717
http://dx.doi.org/10.4254/wjh.v14.i9.1718
work_keys_str_mv AT shenkatie therapiesfornonalcoholicfattyliverdiseasea2022update
AT singhachintyad therapiesfornonalcoholicfattyliverdiseasea2022update
AT modaresiesfehjamak therapiesfornonalcoholicfattyliverdiseasea2022update
AT wakimflemingjamile therapiesfornonalcoholicfattyliverdiseasea2022update

Ejemplares similares